The mutational signature of chronic lymphocytic leukemia.

Abstract excerpt

Advances in next-generation sequencing technologies continue to unravel the cancer genome, identifying key biological pathways important for disease pathogenesis and clinically relevant genetic lesions. These studies have provided unprecedented resolution of the cancer genome, facilitating significant advances in the ability to detect many cancers, and predict patients who will develop an aggressive disease or...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genome, Human
• Share to High-Throughput Nucleotide Sequencing
• Share to Leukemia, Lymphocytic, Chronic, B-Cell